Heart Xenotransplantation: Historical Background, Experimental Progress, and Clinical Prospects
Authors:
- 1 April 2016
- journal article
- review article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 101 (4) , 1605-1613
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 58 references indexed in Scilit:
- Human dominant‐negative class II transactivator transgenic pigs – effect on the human anti‐pig T‐cell immune response and immune statusImmunology, 2013
- Double knockout pigs deficient in N‐glycolylneuraminic acid and Galactose α‐1,3‐Galactose reduce the humoral barrier to xenotransplantationXenotransplantation, 2013
- Human CD55 Expression Blocks Hyperacute Rejection and Restricts Complement Activation in Gal Knockout Cardiac XenograftsTransplantation, 2012
- Infection Barriers to Successful Xenotransplantation Focusing on Porcine Endogenous RetrovirusesClinical Microbiology Reviews, 2012
- Innate immunity and coagulationJournal of Thrombosis and Haemostasis, 2011
- Controlling coagulation dysregulation in xenotransplantationCurrent Opinion in Organ Transplantation, 2011
- Recipient Tissue Factor Expression Is Associated With Consumptive Coagulopathy in Pig‐to‐Primate Kidney XenotransplantationAmerican Journal of Transplantation, 2010
- Increased Immunosuppression, Not Anticoagulation, Extends Cardiac Xenograft SurvivalTransplantation, 2006
- HIGH-DOSE PORCINE HEMATOPOIETIC CELL TRANSPLANTATION COMBINED WITH CD40 LIGAND BLOCKADE IN BABOONS PREVENTS AN INDUCED ANTI-PIG HUMORAL RESPONSETransplantation, 2000
- Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Gal?1?3Gal), blood group H determinant andN-glycolylneuraminic acidGlycoconjugate Journal, 1996